Skip to content

Neodocs Pioneers Smartphone-based Lab Testing for Remote Healthcare Access

Neodocs revolutionizes healthcare with a platform offering instant lab tests via smartphones. Neodocs democratizes access to health diagnostics, providing accurate results instantly. Backed by Y Combinator, Neodocs aims to make lab tests accessible to all.

  • Neodocs is a pioneering platform that offers instant lab tests that can be completed using a smartphone, eliminating the need for traditional lab visits and providing accurate results instantly.
  • It aims to democratize access to healthcare, making essential lab tests available to anyone, anywhere.
  • With its user-friendly interface, reliable results, and focus on improving accessibility and accuracy, Neodocs is bringing essential lab tests to the fingertips of millions and empowering individuals to take control of their health.

Lab tests are a crucial component of diagnosis and treatment in healthcare. Oftentimes, it involves wait times which can be lengthy and inconvenient clinic visits that can cause delays.

Although the traditional model of lab testing is time-consuming, it also can be inaccessible to those in remote areas. This can cause delayed diagnosis and ineffective treatments.

In this constantly evolving healthcare sector, Neodocs stand out against such a backdrop where lab results are brought out instantly.

The platform paves the way to transform the industry by making lab tests accessible on smartphones, thus breaking barriers to accessing healthcare and making the process quicker.

The Key to Instant Lab Results

Built on a vision to democratize healthcare access, Neodocs serves to make essential lab tests available to anyone who can access a smartphone.

By leveraging the technology at hand, the Indian-based visionary ventureship aims to address the long-standing issue of inaccessibility to resources in healthcare due to specific limitations.

Neodocs offers test kits for kidney diseases and UTIs, while also providing wellness care, pregnancy care, and elderly care kits.

By making kidney and liver care accessible with accurate data, ready in under 60 seconds, the platform is transforming the way healthcare is perceived across the country.

The kit contains a card that will detect the presence of specific proteins and ketones which can be scanned using a QR code through the mobile application to access the lab results.

The results are displayed instantly and allow the user to proceed with any necessary and immediate action if required.

Behind the success of Neodocs, stand proud, three brilliant minds, who were all young graduates from IIT Bombay, who envisioned building the future of diagnostics.

The co-founders of Neodocs, Nikunj Malpani, Pratik Lodha and Anurag Meena have successfully spearheaded this healthcare revolution across India.

"We are changing the way healthcare is delivered to 1.3B Indians by bringing the in-clinic accuracy to comfort of your home.
Solving the problems of access, quality, standardization, convenience and affordability for the masses." Pratik Lodha remarks.

The company has already sold 200,000 urine-based tests for Kidney and UTI care kits and has been adopted by more than 4,000 doctors across India.

The Real-world Applications of Neodocs

By bypassing the hassles of traditional lab tests with the substitute placement of the mobile phone application, Neodocs offers a quick, effortless, and efficient solution to this dilemma.

The platform not only enhances convenience, it allows individuals to take complete control of their health and make informed decisions.

As it also reaches a wider audience, often underserved demographics, it also bridges the gap in healthcare disparities.

Neodocs serve to ease the process of early detection of troublesome chronic diseases, thereby reducing the risk of complications.

The Future Diagnosis of Neodocs

Neodocs has been successful in gaining considerable traction since its conception among various investors and is even backed by Y Combinator's accelerator program.

Having secured $2M seed funding from Omidyar Network, Neodocs has effectively collaborated with major pharmaceutical firms such as Cipla, Sun Pharma, and AstraZeneca.

"To ensure sustainability, we are approaching things a little differently. Today, a major part of our focus is getting these tests at doctor clinics. Imagine the power of that! [...] we are trying to build advocacy with doctors, trying to work with them. That will set us for long term success."
Nikunj Malpani, CEO and Co-Founder, Neodocs, told Newzchain as he discusses the revolutionary advances in diagnostics on The Newzchain Podcast.

The platform's mission to democratize healthcare is evident in its innovative approach and user-friendly design.

Neodoc focuses on improving accuracy and accessibility to ensure everyone can benefit from an instant and reliable diagnostic system.


Edited By Annette George

Latest